Tanabe Pharma Corporation

This study tested a new vaccine called MT-2301 to protect healthy infants against Haemophilus influenzae type b (Hib) disease. The vaccine was given alongside routine DPT-IPV shots, and its safety and ability to produce protective antibodies were compared to an existing Hib vacci…

This study tested an experimental daily pill (TA-7284) in 383 adults with type 2 diabetes to see if it safely lowers blood sugar and helps with weight. Participants took either the drug or a placebo for several weeks. The main goal was to measure changes in HbA1c (average blood s…

This study tested a drug called MCI-186 (edaravone) in 181 people with ALS, a serious nerve disease that weakens muscles over time. The goal was to see if the drug could slow down the disease and keep patients functioning longer. Participants received either the drug or a placebo…

This study tested a drug called MCI-186 in 36 adults who had a recent ischemic stroke (a clot blocking blood flow to the brain). The main goal was to check if the drug is safe and how the body processes it. Participants received the drug or a placebo within 1 to 24 hours after th…

This study tested whether adding canagliflozin to teneligliptin helps Japanese adults with type 2 diabetes who are not well controlled on teneligliptin alone. 138 participants took the combination daily for 24 weeks. The main goal was to see if it lowered blood sugar levels (HbA1…

This study tested the long-term safety and effectiveness of the drug MP-513 (Teneligliptin) in 462 Japanese adults with type 2 diabetes. Participants took the drug alone or with other diabetes pills for 52 weeks. The main goal was to track side effects, and researchers also measu…

This study looked at the long-term safety and tolerability of the drug MP-214 in 254 adults with schizophrenia. Participants had already completed an earlier study and continued taking MP-214 to see how well it was tolerated over time. The main focus was on tracking any side effe…

This study tested a daily pill called MT-5199 to see if it could reduce symptoms of tardive dyskinesia, a condition that causes uncontrollable movements of the face, mouth, arms, legs, and trunk. The study involved 256 adults with moderate to severe tardive dyskinesia who also ha…

This study looked at how a new drug called MP-214 works in 38 adults with schizophrenia. Researchers measured safety, how the drug moves through the body, and whether it helps control symptoms over 12 weeks. The goal was to find the right dose and check for side effects.

This study looked at how eating different types of meals changes the way the body absorbs and processes an oral form of edaravone. Sixteen healthy Japanese adults took the drug under various meal conditions, including fasting. The goal was to gather information, not to treat any …

This study looked at how the drug MCI-186 moves through the body in people with severe liver damage compared to healthy people. Researchers gave a single dose to 12 adults and measured drug levels and side effects. The goal was to understand if liver problems change how the drug …